GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » EBITDA Margin %

Stealth BioTherapeutics (Stealth BioTherapeutics) EBITDA Margin % : 0.00% (As of Mar. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Stealth BioTherapeutics's EBITDA for the three months ended in Mar. 2022 was $-7.60 Mil. Stealth BioTherapeutics's Revenue for the three months ended in Mar. 2022 was $0.00 Mil. Therefore, Stealth BioTherapeutics's EBITDA margin for the quarter that ended in Mar. 2022 was 0.00%.


Stealth BioTherapeutics EBITDA Margin % Historical Data

The historical data trend for Stealth BioTherapeutics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics EBITDA Margin % Chart

Stealth BioTherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBITDA Margin %
Get a 7-Day Free Trial - - -307.19 - -

Stealth BioTherapeutics Quarterly Data
Dec16 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stealth BioTherapeutics's EBITDA Margin %

For the Biotechnology subindustry, Stealth BioTherapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stealth BioTherapeutics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's EBITDA Margin % falls into.



Stealth BioTherapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Stealth BioTherapeutics's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-51.208/0
= %

Stealth BioTherapeutics's EBITDA Margin % for the quarter that ended in Mar. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )
=-7.595/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stealth BioTherapeutics  (NAS:MITO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Stealth BioTherapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus